<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BIO
Bio-Rad
$
()


  • Early notable gainers among liquid option names on June 17th

    6/17/2024 - 09:55am
  • Bio-Rad says will need to update prior long-term outlook given market conditions

    6/6/2024 - 11:40am
  • Bio-Rad assumed with a Hold from Buy at Jefferies

    6/3/2024 - 04:54am
  • Bio-Rad affirms 2204 revenue growth outlook of 1.0%-2.5%

    5/7/2024 - 16:25pm
  • Bio-Rad reports Q1 EPS $2.29, consensus $2.15

    5/7/2024 - 16:24pm
  • Fly Intel: After-Hours Movers

    4/11/2024 - 18:23pm
  • OncoCyte, BioRad to partner on global launch of GraftAssure assay

    4/11/2024 - 17:31pm
  • Bio-Rad COO Andrew Last to retire

    4/10/2024 - 16:15pm
  • UPS upgraded, PepsiCo downgraded: Wall Street's top analyst calls

    4/3/2024 - 09:54am
  • Bio-Rad downgraded to Neutral on limited visibility at Citi

    4/3/2024 - 05:56am
  • Citi gets more bearish on Bio-Rad, downgrades shares

    4/3/2024 - 05:39am
  • Bio-Rad appoints Roop Lakkaraju EVP, CFO

    3/20/2024 - 08:41am
  • Early notable gainers among liquid option names on February 16th

    2/16/2024 - 09:55am
  • Bio-Rad sees FY24 revenue up 1%-2.5%

    2/15/2024 - 16:23pm
  • Bio-Rad reports Q4 EPS $3.10, consensus $2.82

    2/15/2024 - 16:20pm
dynamic_feed Breaking News